A Randomized, Double-Blind, Phase I Dose-Escalation Study of the Novel Retinoid 9cUAB30

Grant

Date/time Interval

  • July 1, 2015 - March 31, 2017
  • Total Award Amount

  • 73267.00
  • Direct Costs

  • 72983.00
  • Sponsor Award Id

  • 657K672
  • Contributor

  • Krontiras M.D., Helen   Principal Investigator